Application 204984
- Type
- ANDA
- Sponsor
- CNTY LINE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | TABLET;ORAL | 325MG;50MG;40MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-536 | Butalbital, Acetaminophen, and Caffeine | butalbital, acetaminophen, and caffeine | Alvogen Inc. | ANDA | Current |
| 47781-625 | Butalbital, Acetaminophen, and Caffeine | butalbital, acetaminophen, and caffeine | Alvogen Inc. | ANDA | Current |
| 47781-625 | Butalbital, Acetaminophen, and Caffeine | butalbital, acetaminophen, and caffeine | Alvogen Inc. | ANDA | Current |
| 47781-625 | Butalbital, Acetaminophen, and Caffeine | butalbital, acetaminophen, and caffeine | Alvogen Inc. | ANDA | Current |